Danish dermatology specialist Leo Pharma and its CEO Christophe Bourdon came to San Francisco to attend the J.P. Morgan ...

Tremfya and Icotide are touted as key growth drivers in J&J’s strongly performing innovative medicines business.

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The ...

AbbVie reached a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future ...

Director Srinivas Akkaraju of Alumis INC. (NASDAQ:ALMS) acquired 588,235 shares of common stock on January 9, 2026, at a price of $17.0, in one transaction. The total value of the purchase was $9,999, ...

AI prioritizes clinical trials by identifying unmet medical needs, optimizing resource allocation, and focusing on conditions ...

After a whirlwind of conference news Monday, we're doing it all over again with Day 2 of the J.P. Morgan Healthcare ...

According to DataM Intelligence, the global Inflammatory Diseases Biologics Market was valued at USD 99.06 billion in 2024 and is projected ...

“Self-exams can help you identify potential skin cancers early, allowing for prompt treatment. If you have persistent dry ...

Foresite Labs, LLC and Foresite Labs Affiliates 2021, LLC, both identified as ten percent owners of Alumis Inc (NASDAQ:ALMS), have purchased a total of 411,764 shares of common stock in Alumis on ...

Learn about 5 habits that speed up skin ageing: not getting enough sleep, eating unhealthy food, and not taking care of your ...